Homrich & Berg’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-26,897
Closed -$1.36M 311
2019
Q4
$1.36M Sell
26,897
-1,582
-6% -$81.7K 0.06% 134
2019
Q3
$1.34M Buy
28,479
+2,635
+10% +$120K 0.07% 124
2019
Q2
$1.22M Buy
25,844
+4,182
+19% +$193K 0.06% 129
2019
Q1
$1.04M Buy
21,662
+13,028
+151% +$653K 0.05% 133
2018
Q4
$385K Sell
8,634
-1,331
-13% -$69.4K 0.02% 212
2018
Q3
$538K Sell
9,965
-4,084
-29% -$209K 0.03% 190
2018
Q2
$686K Buy
14,049
+3,414
+32% +$194K 0.05% 166
2018
Q1
$667K Buy
10,635
+5,472
+106% +$375K 0.05% 182
2017
Q4
$316K Sell
5,163
-4,670
-47% -$289K 0.02% 249
2017
Q3
$658K Buy
9,833
+681
+7% +$48.1K 0.05% 158
2017
Q2
$713K Buy
9,152
+1,563
+21% +$118K 0.06% 130
2017
Q1
$619K Buy
+7,589
New +$597K 0.05% 151

Other funds holding CAH

Homrich & Berg's CAH Position: Q1 2020 in Review

Homrich & Berg sold out of Cardinal Health (CAH) in Q1 2020, closing a stake of 26,897 shares — an estimated $1.36M sold.

Homrich & Berg first reported a position in CAH in Q1 2017 and held it in 12 quarters. The position peaked at $1.36M in Q4 2019. 721 funds tracked by Wall St. Rank hold CAH as of Q1 2020.

  • Homrich & Berg reported no remaining Cardinal Health position as of Q1 2020 after selling out during the quarter.
  • Homrich & Berg sold 26,897 Cardinal Health shares in Q1 2020, an estimated $1.36M.
  • Homrich & Berg first reported a position in Cardinal Health in Q1 2017 and held it in 12 quarters.
  • Homrich & Berg's Cardinal Health position peaked at $1.36M in Q4 2019.
  • 721 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2020.

Based on Homrich & Berg's 13F filing for Q1 2020, filed 8 May 2020.